Emergent Pledges FDA Improvements at Troubled Vaccine Plant

Emergent BioSolutions Inc. is promising the Food and Drug Administration a sequence of fixes in response to an inspection that led to a halt in manufacturing at an organization facility that had been making Johnson & Johnson’s Covid-19 vaccine.
Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here